After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and ...

US firm PVH, which owns Tommy Hilfiger and Calvin Klein, said today it was “deeply disappointed” by China’s decision to place ...

IQVIA Holdings Inc. (NYSE:IQV), a global leader in advanced analytics, technology solutions, and clinical research services for the healthcare and life sciences industries, finds itself at a critical ...

The healthcare industry is set for growth due to advancements in targeted treatments and personalized care and the rapid ...

Reducing reliance on Earth-supplied feedstocks is crucial for advancing in-space biomanufacturing. Here, the authors explored three alternative feedstocks – Martian and Lunar regolith, post ...

Invest in SPDR S&P Biotech ETF (XBI) for long-term growth potential and diverse, equal-weighted portfolio in the biotech ...

Peter Mayhew, Principal Analyst at Keypoint Intelligence, will deliver two dynamic presentations at the Remanexpo Academy, part of Ambiente 2025 ...

The Trump administration is bringing new instability to a sector already grappling with a shaky market as well as threats ...

Andrew Young is an influential leader in the biotechnology sector, serving as the CEO and Managing Partner of Conjugate Group ...

The "Global Biotech Handbook 2025" has been added to ResearchAndMarkets.com's offering. The fully revised and expanded Global Biotech Handbook provides biotechnology industry decision-makers with a ...

Ascentage’s Wall Street debut is a test of U.S. investors’ interest in the progress China’s biotech sector has made. Efforts by the Chinese government to boost the country’s capabilities have produced ...